316 related articles for article (PubMed ID: 32510610)
1. On point in primary CNS lymphoma.
Tsang M; Cleveland J; Rubenstein JL
Hematol Oncol; 2020 Dec; 38(5):640-647. PubMed ID: 32510610
[TBL] [Abstract][Full Text] [Related]
2. Primary central nervous system lymphoma: A curable disease.
Batchelor TT
Hematol Oncol; 2019 Jun; 37 Suppl 1():15-18. PubMed ID: 31187523
[TBL] [Abstract][Full Text] [Related]
3. Progress in central nervous system lymphomas.
Wang CC; Carnevale J; Rubenstein JL
Br J Haematol; 2014 Aug; 166(3):311-25. PubMed ID: 24837460
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
5. Evolving Treatments for Primary Central Nervous System Lymphoma.
Ferreri AJM; Holdhoff M; Nayak L; Rubenstein JL
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():454-466. PubMed ID: 31099614
[TBL] [Abstract][Full Text] [Related]
6. Consolidation Therapy in Primary Central Nervous System Lymphoma.
Kim P; Omuro A
Curr Treat Options Oncol; 2020 Jul; 21(9):74. PubMed ID: 32725379
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and management of primary CNS lymphoma.
Roth P; Korfel A; Martus P; Weller M
Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of primary CNS lymphoma.
Korfel A; Schlegel U
Nat Rev Neurol; 2013 Jun; 9(6):317-27. PubMed ID: 23670107
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphoma: an update.
Soussain C; Hoang-Xuan K
Curr Opin Oncol; 2009 Nov; 21(6):550-8. PubMed ID: 19684518
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic, Pathologic, and Therapeutic Considerations for Primary CNS Lymphoma.
D'Angelo CR
JCO Oncol Pract; 2024 Feb; 20(2):195-202. PubMed ID: 37967301
[TBL] [Abstract][Full Text] [Related]
11. Central Nervous System Lymphoma.
Shah T; Venur VA
Semin Neurol; 2023 Dec; 43(6):825-832. PubMed ID: 37995744
[TBL] [Abstract][Full Text] [Related]
12. How I treat CNS lymphomas.
Rubenstein JL; Gupta NK; Mannis GN; Lamarre AK; Treseler P
Blood; 2013 Oct; 122(14):2318-30. PubMed ID: 23963042
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?
Royer-Perron L; Hoang-Xuan K; Alentorn A
Curr Opin Neurol; 2017 Dec; 30(6):669-676. PubMed ID: 28922238
[TBL] [Abstract][Full Text] [Related]
14. [Primary CNS lymphoma--an update].
Soussain C; Houillier C; Choquet S; Hoang-Xuan K
Bull Cancer; 2014 Mar; 101(3):314-24. PubMed ID: 24691194
[TBL] [Abstract][Full Text] [Related]
15. Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.
Ponzoni M; Issa S; Batchelor TT; Rubenstein JL
Ann Oncol; 2014 Feb; 25(2):316-22. PubMed ID: 24265352
[TBL] [Abstract][Full Text] [Related]
16. Current management of primary central nervous system lymphoma.
Schultz CJ; Bovi J
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in the treatment of primary central nervous system lymphoma].
Nakamaki T
Brain Nerve; 2014 Aug; 66(8):969-79. PubMed ID: 25082318
[TBL] [Abstract][Full Text] [Related]
18. International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future.
Nussenblatt RB; Chan CC; Wilson WH; Hochman J; Gottesman M;
Ocul Immunol Inflamm; 2006 Jun; 14(3):139-44. PubMed ID: 16827214
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma: essential points in diagnosis and management.
Paydas S
Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
[TBL] [Abstract][Full Text] [Related]
20. Advances in Primary Central Nervous System Lymphoma.
Patrick LB; Mohile NA
Curr Oncol Rep; 2015 Dec; 17(12):60. PubMed ID: 26475775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]